Hemp For Depression
Hemp For Depression-Relevant studies has shown that cannabinoids in industrial hemp can exert therapeutic effects by regulating the endocannabinoid system (ECS).
From CDC data from 1990 to 2007, Dr. Anderson and his team,
Analyzing the effect of medical marijuana legalization on suicide rates, the study showed:
Medical marijuana legalization was associated with a 5 percent decrease in overall suicide rates, an 11 percent decrease in suicide rates among men ages 20 to 29, and a 9 percent decrease in suicide rates among men ages 30 to 39.”
The team of Professor Li Xiaoming of Zhejiang University School of Medicine also identified candidate genes expressing pleasure and aversion in the amygdala through experiments and discovered a new neural circuit involved in the pathogenesis of depression. The results of this study are of great significance to patients with depression. Because the amygdala, known as the “danger alarm button”, is repeatedly activated when the patient’s negative emotional stimuli are continuously triggered by the outside world, and negative emotions are expressed.
What’s more, they found that outside administration of synthetic cannabis reversed social stress-induced depressive behaviors. Cannabis has been shown to relieve symptoms of depression.
CBD For Depression
CBD (cannabidiol), the main cannabinoid in industrial hemp.
Extracted from female cannabis plants, Hemp For Depression is a non-addictive ingredient in cannabis, with antispasmodic, anti-anxiety, anti-inflammatory, and other pharmacological effects, and is widely used in medical, skincare, and other fields.
Clinical trials have shown that rational use of CBD can reduce depression, greatly improve people’s acceptance of the perception of pleasure, and is quite effective as an anxiolytic and antidepressant.
Compared with ordinary antidepressants, CBD can have a positive interaction with serotonin in the human body and does not produce the side effects of ordinary antidepressants. Maintaining a balanced level of serotonin will greatly improve people’s acceptance of pleasure perception. It is an important treatment method for patients with depression.
In 2019, a non-profit organization promoting the medical use of CBD and other cannabinoids in the United States surveyed more than 3,000 CBD users from different countries with different symptoms of depression. The report shows:
92% experienced some relief, while 68% reported feeling “much better” from the often jittery feeling after using CBD. CBD has been proven to work excellently in relieving panic attacks, relieving mood swings, and eliminating feelings of restlessness, irritability, and sadness.
CBC For Depression
CBC (cannabinoid) is the most common cannabinoid in industrial hemp after THC and CBD. It is distributed throughout the plant, and in some industrial hemp plants, the content of CBC is higher than that of CBD.
Like CBD, CBC is an inactive ingredient and has no hallucinogenic or addictive side effects. A 1996 study found that CBC binds to receptors that sense pain but do not affect cannabinoid receptors in the brain. So that’s why even if it heals severe pain, it won’t get you excited.
Researchers from the University of Mississippi conducted a tail-hanging experiment on the antidepressant effect of CBC. Hang the mouse by its tail and watch the mouse struggle to escape. The more struggling the mouse, the better the mood and the lower the depression.
The results showed that the mice given CBC struggled significantly more than those given other cannabinoids, and the amount of time the mice struggled depended on the dose of CBC given to the mice. The results confirmed that CBC does have antidepressant efficacy.
CBG For Depression
CBG (cannabinol) is a cannabinoid that exists in the early stage of industrial hemp growth. The content of CBG in hemp plants is very small, usually about one percent.
The pharmacological effects of CBG described in the research literature include antifungal, anti-inflammatory, and analgesic, lowering intraocular pressure, antidepressant, stimulating appetite, protecting nerves, etc. Back in 1975, researchers discovered that CBG is a moderate antidepressant and that CBG helps raise serotonin levels in the brain.
In 2006, Richard Hemme and Richard Dayou discovered the antidepressant effect of CBG in experiments on mice. While CBG has yet to go mainstream like CBD, the cannabinoid has quietly demonstrated a range of attractive medical benefits. Interacting with CB1 and CB2 cannabinoid receptors, CBG inhibits the intoxicating effects of THC, and has also been shown to increase endocannabinoids that help regulate various bodily functions, including appetite, sleep, mood, and the immune system.